GlassScriptPhysician profile
Lokesh Chandra
NPI 1942363254
$8,401.30
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,743 · 2020: $2,842 · 2021: $1,341 · 2022: $262 · 2023: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,060.01 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $677.28 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $470.00 | 2019-2021 | |
| Glaxosmithkline, LLC. | $303.37 | 2019-2022 | |
| Amgen INC. | $229.50 | 2019-2022 | |
| Novo Nordisk INC | $181.24 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $163.47 | 2019-2022 | |
| Lilly USA, LLC | $157.42 | 2019-2022 | |
| Biotronik INC. | $156.51 | 2019-2022 | |
| Preventric Diagnostics, INC. | $115.64 | 2021 | |
| Pfizer INC. | $115.61 | 2019-2021 | |
| Amarin Pharma, INC. | $93.72 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $79.73 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $79.25 | 2019-2021 | |
| Esperion Therapeutics, INC. | $64.43 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $53.38 | 2019 | |
| Vifor Pharma, INC. | $52.94 | 2020 | |
| Sanofi-Aventis U.S. LLC | $47.26 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $45.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $43.96 | 2019 | |
| Allergan, INC. | $35.37 | 2019 | |
| Arbor Pharmaceuticals, INC. | $35.06 | 2019 | |
| Edwards Lifesciences Corporation | $20.08 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2020 | |
| Boston Scientific Corporation | $17.38 | 2019 | |
| Medtronic, INC. | $16.47 | 2021 | |
| Medicomp INC | $15.66 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.24 | 2021 | |
| Itamar Medical INC | $12.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.48 | 2021 | |
| Bardy Diagnostics, INC. | $12.00 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lokesh Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.